2019 · Journal of clinical microbiology · open access
Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> in Male and Female Urogenital Samples
Van Der Pol et al.
The finding, in our words
The Cobas CT/NG assay demonstrated high sensitivity (95.6–100%) and specificity (≥98.8%) for detecting Chlamydia trachomatis and Neisseria gonorrhoeae across urine and self-collected vaginal swabs from men and women. This validates patient-centric self-sampling for accurate, high-throughput STI screening suitable for decentralised public health programmes.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.